hsa-mir-192 |
FGF2 |
Fibroblast Growth Factor 2 |
Combined Model |
hsa-mir-192 |
ITGAV |
integrin subunit alpha V |
Combined Model |
hsa-mir-192 |
LOXL2 |
lysyl oxidase-like 2 |
Combined Model |
hsa-mir-192 |
ITGB1 |
integrin subunit beta 1 |
Combined Model |
hsa-mir-192 |
PLOD1 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
Combined Model |
hsa-mir-192 |
PXDN |
peroxidasin |
Combined Model |
hsa-mir-192 |
SPARC |
Secreted Protein Acidic And Cysteine Rich |
Combined Model |
hsa-mir-192 |
DST |
Dystonin |
Combined Model |
hsa-mir-192 |
FBN1 |
Fibrillin 1 |
Combined Model |
hsa-mir-192 |
FN1 |
Fibronectin 1 |
Binding site analysis |
hsa-mir-192 |
KDR |
Kinase Insert Domain Receptor |
Binding site analysis |
hsa-mir-192 |
MMP2 |
Matrix Metallopeptidase 2 |
Binding site analysis |
hsa-mir-192 |
TGFB1 |
Transforming Growth Factor Beta 1 |
Binding site analysis |
hsa-mir-200c |
ETS1 |
ETS Proto-Oncogene 1 |
Combined Model |
hsa-mir-200c |
KDR |
Kinase Insert Domain Receptor |
Combined Model |
hsa-mir-200c |
SERPINH1 |
Serpin Family H Member 1 |
Combined Model |
hsa-mir-200c |
TIMP2 |
TIMP Metallopeptidase Inhibitor 2 |
Combined Model |
hsa-mir-200c |
NCAM1 |
Neural Cell Adhesion Molecule 1 |
Combined Model |
hsa-mir-200c |
FN1 |
Fibronectin 1 |
Combined Model |
hsa-mir-200c |
FBLN5 |
Fibulin 5 |
Combined Model |
hsa-mir-200c |
DST |
Dystonin |
Binding site analysis |
hsa-mir-200c |
FGF2 |
Fibroblast Growth Factor 2 |
Binding site analysis |
hsa-mir-200c |
ITGAV |
integrin subunit alpha V |
Binding site analysis |
hsa-mir-200c |
ITGB1 |
integrin subunit beta 1 |
Binding site analysis |
hsa-mir-200c |
PLOD1 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
Binding site analysis |
hsa-mir-200c |
SPARC |
Secreted Protein Acidic And Cysteine Rich |
Binding site analysis |
hsa-mir-17 |
MMP2 |
Matrix Metallopeptidase 2 |
Combined Model |
hsa-mir-17 |
FSCN1 |
Fascin Actin-Bundling Protein 1 |
Combined Model |
hsa-mir-17 |
LAMC1 |
Laminin Subunit Gamma 1 |
Combined Model |
hsa-mir-17 |
TGFB1 |
Transforming Growth Factor Beta 1 |
Combined Model |
hsa-mir-17 |
DST |
Dystonin |
Binding site analysis |
hsa-mir-17 |
ETS1 |
ETS Proto-Oncogene 1 |
Binding site analysis |
hsa-mir-17 |
FBN1 |
Fibrillin 1 |
Binding site analysis |
hsa-mir-17 |
FGF2 |
Fibroblast Growth Factor 2 |
Binding site analysis |
hsa-mir-17 |
FN1 |
Fibronectin 1 |
Binding site analysis |
hsa-mir-17 |
ITGAV |
integrin subunit alpha V |
Binding site analysis |
hsa-mir-17 |
ITGB1 |
integrin subunit beta 1 |
Binding site analysis |
hsa-mir-17 |
PXDN |
peroxidasin |
Binding site analysis |
hsa-mir-17 |
TIMP2 |
TIMP Metallopeptidase Inhibitor 2 |
Binding site analysis |